Neovascular Glaucoma Clinical Trial
Official title:
Avastin as an Adjunct to Diode Laser Cyclophotoablation in the Treatment of Neovascular Glaucoma
Assess the efficacy of Avastin as an adjunct to Diode Laser cyclophotocoagulation in the treatment of Neovascular Glaucoma.
Design: Prospective, comparative interventional case series. Method: Patients were randomly assigned into Group A which were treated with Diode laser cyclophotocoagulation alone, whereas group B received intravitreal Avastin (One milligram = 0.04mL of 25 mg/mL) in conjunction with the Diode Laser. The preoperative data included etiology, mean age; follow up period, and a full ophthalmological examination with emphasis on mean IOP, iris neovascularization, pain and corneal edema. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT00491712 -
Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection
|
N/A | |
Recruiting |
NCT04519619 -
Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)
|
||
Completed |
NCT01370135 -
Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma
|
N/A | |
Completed |
NCT04970251 -
Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma
|
N/A | |
Completed |
NCT02805257 -
Ahmed Glaucoma Valve Surgery With Mitomycin-C
|
Phase 2 | |
Recruiting |
NCT02067013 -
Analysis of Aqueous and Vitreous Humor
|
Phase 2 | |
Completed |
NCT00524758 -
Oculusgen (Ologen) Glaucoma MMC Control in Estonia
|
Phase 3 | |
Withdrawn |
NCT00727038 -
Lucentis for New Onset Neovascular Glaucoma
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT02947867 -
Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG
|
Phase 2/Phase 3 | |
Completed |
NCT01711879 -
Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma
|
N/A | |
Terminated |
NCT02260219 -
Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular Glaucoma
|
N/A | |
Withdrawn |
NCT00441181 -
Effects of Travoprost on Neovascular Glaucoma
|
N/A | |
Completed |
NCT05156021 -
A Study on the Treatment Strategy of NVG Secondary to PDR
|
N/A | |
Terminated |
NCT01301378 -
Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube
|
N/A | |
Not yet recruiting |
NCT05316142 -
Any Unique Identifier Assigned to the Protocol by the Sponsor
|
N/A | |
Recruiting |
NCT04844619 -
KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial
|
Phase 1 | |
Completed |
NCT03154892 -
The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma
|
N/A |